The Association Between Polymorphisms in Glutathione S-Transferase (GSTM1 and GSTT1) and Lung Cancer Outcome

REFERENCES

• Pinarbasi H., Silig Y., Cetinkaya O., Seyfikli Z., Pinarbasi E. Strong association between the GSTM1-null genotype and lung cancer in a Turkish population. Cancer Genetic Cytogenet. 2003; 146: 125–129, [CSA]
   PubMed Web of Science ®Google Scholar
• Benhamou S., Lee W. J., Alexandrie A. K., Boffetta P., Bouchardy C., et al. Meta-and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis 2002; 23: 1343–1350, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Houlston R. S. Glutathione S-transferase M1 status and lung cancer risk: a meta-analysis. Cancer Epidemiol. Biomark. Prev. 1999; 8: 675–682, [CSA]
   PubMed Web of Science ®Google Scholar
• Hayes J. D., Pulford D. J. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit. Rev. Biochem. Mol. Biol. 1995; 30: 445–460, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Mc Williams J. E., Sanderson B. J., Harris E. L., Richert-Boe K. E., Henner W. D. Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer. Epidemiol. Biomark. Prev. 1995; 4: 589–594, [CSA]
   PubMed Web of Science ®Google Scholar
• Pinarbasi H., Silig Y., Gurelik M. Genetic polymorphisms of GSTs and their association with primary brain tumor incidence. Cancer Genetic. Cytogenet. 2005; 156: 144–149, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• London S. J., Yuan J. M., Chung F. L., Gao Y. T., Coetzee G. A., Ross R. K., Yu M. C. Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung cancer risk: a prospective study of men in Shanghai, China. Lancet 2000; 356: 724–729, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Shen H., Kauvar L., Tew K. D. Importance of glutathione and associated enzymes in drug response. Oncol Res 1997; 9: 253–302, [CSA]
   Google Scholar
• Carmichael J., Mitchell J. B., Friedman N., Gazdar A. F., Russo A. Glutathione and related enzyme activity in human lung cancer cell lines. Br. J. Cancer 1988; 58: 437–440, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Gulick A. M., Fahl W. E. Mammalian glutathione S-transferase: regulation of enzyme system to achieve chemotherapeutic efficacy. Pharmacol. Ther. 1995; 66: 237–257, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Goto S., Iida T., Cho S., Oka M., Kohno S., Kondo T. Overexpression of glutathione S-transferase pi enhances the adduct formation of cisplatin with glutathione in human cancer cells. Free. Radic. Res. 1999; 31: 549–558, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• World Health Organization. Histological typing of lung tumours. International classification of tumours, second edition. WHO, Geneva 1981, No. 1
   Google Scholar
• Oken M. M., Creech R. H., Tormey D. C., Horton J., Davis T. E., McFadden E. T., Carbone P. P. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am. J. Clin. Oncol. 1982; 5: 649–655, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Miller S. A., Dykes D. D., Polesky H. F. A simple salting-out procedure for extracting DNA from human nucleated cells. Nucleic. Acids. Res. 1988; 16: 1215, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Ge H., Lam W. K., Lee J., Wong M. P., Yew W. W., Lung M. L. Analysis of L-myc and GSTM1 genotypes in Chinese non-small cell lung carcinoma patients. Lung. Cancer. 1996; 15: 355–366, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Przygodzki R. M., Bennett W. P., Guinee D. G., jr., Khan M. A., Freedman A., Shields P. G., Travis W. D., Jett J. R., Tazelar H., Pairolero P., Trastek V., Liotta L. A., Harris C. C. Caporaso NE p53 mutation spectrum in relation to GSTM1, CYP1A1 and CYP2E1 in surgically treated patients with non-small cell lung cancer. Pharmacogenetics. 1998; 8: 503–511, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Yang P., Yokomizo A., Tazelaar H. D., Marks R. S., Lesnick T. G., Miller D. L., Sloan J. A., Edell E. S., Meyer R. L., Jett J., Liu W. Genetic determinants of lung cancer short-term survival: the role of glutathione-related genes. Lung. Cancer. 2002; 35: 221–229, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Sweeney C., Nazar-Stewart V., Stapleton P. L., Eaton D. L., Vaughan T. L. Glutathione S-transferas M1, T1, and P1 polymorphisms and survival among lung cancer patients. Cancer. Epidemiol. Biomark. Prev. 2003; 12: 527–533, [CSA]
   PubMed Web of Science ®Google Scholar
• Goto I., Yoneda S., Yamamoto M., Kawajiri K. Prognostic significance of germ-line polymorphisms of the CYP1A1 and glutathione S-transferase genes in patients with non-small cell lung cancer. Cancer. Res. 1996; 56: 3725–3370, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Yellin S. A., Davidson B. J., Pinto J. T., Sacks P. G., Qiao C., Schantz S. P. Relationship of glutathione and glutathione-S-transferase to cisplatin sensitivity in human head and neck squamous carcinoma cell lines. Cancer. Lett. 1994; 85: 223–232, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Sark M. V., Timmer-Bosscha H., Meijer C., Uges D. R., Sluiter W. J., Peters W. H., Mulder N. H., de Vries E. G. Cellular basis for differential sensitivity to cisplatin in human germ cell tumour and colon carcinoma cell lines. Br. J. Cancer. 1995; 71: 684–690, [INFOTRIEVE], [CSA]
   Google Scholar
• Nakanishi Y., Matsuki H., Takayama K., Yatsunami J., Kawasaki M., Abe M., Hara N. Glutathione derivatives enhance adriamycin cytotoxicity in a human lung adenocarcinoma cell line. Anticancer. Res. 1997; 17: 2129–2134, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Chen G., Waxman D. J. Role of cellular glutathione and glutathione S-transferase in the expression of alkylating agent cytotoxicity in human breast cancer cells. Biochem. Pharmacol. 1994; 47: 1079–1087, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Davies S. M., Robison L. L., Buckley J. D., Tjoa T., Woods W. G., Radloff G. A., Ross J. A., Perentesis J. P. Glutathione S-transferase polymorphisms and outcome of chemotherapy in childhood acute myeloid lekemia. J. Clin. Oncol. 2001; 19: 1279–1287, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Cheng S. L., Yu C. J., Chen C. J., Yang P. C. Genetic polymorphism of epoxide hydrolase and glutathione S-transferase in COPD. Eur. Respir. J. 2004; 23: 818–824, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Yim J. J., Park G. Y., Lee C. T., Kim Y. W., Han S. K., Shim Y. S., Yoo C. G. Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and T1. Thorax. 2000; 55: 121–125, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Gilliland F. D., Li Y. F., Saxon A., Diaz-Sanchez D. Effect of glutathione-S-transferase M1 and P1 genotypes on xenobiotic enhancement of allergic responses: randomised, placebo-controlled crossover study. Lancet. 2004; 363: 119–125, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Gonlugur U., Akkurt I., Efeoglu T. Classification of fibreoptic bronchoscopic findings: analysis of 2,698 cases. Comparative. Clinical Pathology 2004; 13: 1–3, [CSA]
   Google Scholar